
pmid: 17040621
Defects in the core machinery of the apoptosis pathway contribute to chemoresistance and poor outcomes in patients with acute leukemia. To overcome these defects, novel molecules that target key proteins in the apoptosis pathway are being developed. This review highlights compounds that target the mitochondrial, death receptor, and convergence pathways of caspase activation that are being developed for the treatment of acute leukemia.
Apoptosis, Receptors, Death Domain, Models, Biological, Leukemia, Lymphoid, Mitochondria, Leukemia, Myeloid, Caspases, Humans, Apoptosis Regulatory Proteins, Signal Transduction
Apoptosis, Receptors, Death Domain, Models, Biological, Leukemia, Lymphoid, Mitochondria, Leukemia, Myeloid, Caspases, Humans, Apoptosis Regulatory Proteins, Signal Transduction
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 4 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
